Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice - Archive ouverte HAL Access content directly
Journal Articles European Heart Journal Year : 2020

Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice

(1) , (2, 3, 4, 5) , (6) , (7) , (8, 9)
1
2
3
4
5
6
7
8
9
Fichier principal
Vignette du fichier
ehaa731.pdf (201.68 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

hal-03010031 , version 1 (17-11-2020)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

Cite

Javed Butler, Faiez Zannad, Gerasimos Filippatos, Stefan D Anker, Milton Packer. Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice. European Heart Journal, 2020, 41 (36), pp.3398-3401. ⟨10.1093/eurheartj/ehaa731⟩. ⟨hal-03010031⟩
14 View
88 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More